Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells

A significant proportion of men diagnosed with prostate cancer (PCa) eventually develop metastatic disease, which progresses to castration resistance, despite initial response to androgen deprivation. As anticancer therapy has become increasingly effective, acquired drug resistance has emerged, limi...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Cell Mol Med
Main Authors: Tsaur, Igor, Hudak, Lukasz, Makarević, Jasmina, Juengel, Eva, Mani, Jens, Borgmann, Hendrik, Gust, Kilian M, Schilling, David, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Ltd 2015
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4549030/
https://ncbi.nlm.nih.gov/pubmed/25808196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12583
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍